Publications
5491 Results
- Journal / Conference
- BMJ Supportive & Palliative Care, May 9;bmjspcare-2022-003593. doi: 10.1136/bmjspcare-2022-003593. Online ahead of print
- Year
- 2022
- PMID
- PMID35534186
Development of a measure of clinicians' self-efficacy for medical communication (SEMC)
- Journal / Conference
- WCLC World Conference on Lung Cancer (August 6-9, 2022, Vienna, Austria), poster
- Year
- 2022
- Research Committee(s)
- Lung
- Study Number(s)
- S0819
External validation of a novel computed tomography (CT)-based prognostic radiomic signature in patients with metastatic non-small cell lung cancer (NSCLC): correlative analysis of SWOG S0819 phase III randomized trial
- Journal / Conference
- ESMO (September 9-13, Paris, France); Annals of Oncology (2022) 33 (suppl_7): S448-S554, poster
- Year
- 2022
- Research Committee(s)
- Lung
- Study Number(s)
- S1800A
Lung-MAP S1800A—Exploratory analysis of prior immunotherapy outcomes on ramucirumab plus pembrolizumab versus SOC for NSCLC with progression on prior immunotherapy
- Journal / Conference
- ESMO (September 9-13, 2022 Paris, France), oral Presidential Symposium; Annals of Oncology (2022) 33 (suppl_7): S808-S869
- Year
- 2022
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1801
Neoadjuvant versus adjuvant pembrolizumab for resected Stage III-IV melanoma (SWOG S1801)
- Journal / Conference
- Journal of Clinical Oncology Jun 1;40(16):1816-1837
- Year
- 2022
- Research Committee(s)
- Breast
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
- Journal / Conference
- International Journal of Radiation Biology Physics VOLUME 114, ISSUE 3, SUPPLEMENT, E414, NOVEMBER 01, 2022;ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), TIP poster
- Year
- 2022
- Research Committee(s)
- Lung
- Study Number(s)
- S1914
SWOG/NRG S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT versus SBRT Alone in High Risk, Early-Stage NSCLC (NCT#04214262)
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 6; abstr 536); ASCO Genitourinary (GU) Cancers Symposium 2022 (Feb 17-19, 2022, San Francisco, CA), poster
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1314
SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up
- Journal / Conference
- JAMA Network Open Oct 3;5(10):e2238191
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36279134
- PMC
- PMC9593234
- Study Number(s)
- S1415CD
Effects of a guideline-informed clinical decision support system intervention to improve colony stimulating factor prescribing: A Pragmatic Cluster-Randomized Trial
- Journal / Conference
- Statistics in Medicine 2022 Oct 30;41(24):4756-4780. doi: 10.1002/sim.9447. Epub 2022 Jul 5
- Year
- 2022
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID36224712
- Study Number(s)
- S0000
Accommodating population differences when validating risk prediction models
- Journal / Conference
- JAMA Network Open 2022 Oct 3;5(10):e2234445
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID36215073
- PMC
- PMC9552895